Adicet Bio (ACET) vs Clene (CLNN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Adicet Bio (ACET) has outperformed Clene (CLNN) over the past year, losing 54.7% versus a loss of 56.8%. Over five years, ACET leads with a -95.2% price change compared with -96.8% for CLNN. Adicet Bio is the larger company by market cap ($56.4 million vs $55.5 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ACET | CLNN |
|---|---|---|
| Share price | $6.02 | $3.91 |
| Market cap | $56.36M | $55.51M |
| 1-day change | -2.58% | -0.38% |
| YTD return | -26.60% | -33.22% |
| 1-year return | -54.72% | -56.78% |
| 5-year return | -95.20% | -96.82% |
| EPS (TTM) | $-10.42 | $-3.52 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $17.44 | $13.50 |
| 52-week low | $6.01 | $3.25 |
| Distance from 52-week high | -65.48% | -71.07% |
| Average volume | 166.29K | 99.70K |
| Shares outstanding | 9.36M | 14.21M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
ACET vs CLNN FAQ
Which is bigger, Adicet Bio or Clene?
Adicet Bio (ACET) is larger, with a market capitalization of $56.36M compared with $55.51M for Clene (CLNN).
Which stock has performed better over the past year, ACET or CLNN?
ACET returned -54.72% over the past 12 months, compared with -56.78% for CLNN (price return, excluding dividends). Past performance does not predict future results.
Are Adicet Bio and Clene in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.